CNIO researchers find a way to increase effectiveness of radiotherapy for brain metastasis

Source: EurekAlert, April 2022

A group of CNIO researchers headed by Manuel Valiente have found a new strategy that could be used in patients with brain metastasis to detect radioresistance.

They found that a simple blood test can help detect patients with resistance to brain radiotherapy and identified a drug that might reverse it. A multi-centre clinical study is now under way to validate the predictive potential of this biomarker through the National Brain Metastasis Network (Spanish acronym: RENACER).

The study is being published in Nature Medicine this week.

READ THE ORIGINAL FULL ARTICLE